Schizophrenia 1 - Clinical (1)

[P147] Change of prescription for patients with schizophrenia during admission: Real-world prescribing surveys from the Effectiveness of Guidelines for Dissemination and Education psychiatric treatment project

*Naoki Hashimoto¹, Norio Yasui-Furukori², Naomi Hasegawa³, Hikaru Hori⁴, Hitoshi Iida⁴, Kayo Ichihashi⁵, Kenichiro Miura³, Junya Matsumoto³, Shusuke Numata⁶, Fumitoshi Kodaka⁷, Ryuji Furihata⁸, Ken Inada⁹, Koichiro Watanabe¹⁰, Ryota Hashimoto³ (1. Department of Psychiatry, Hokkaido University Graduate School of Medicine, Hokkaido, Japan, 2. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 3. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 4. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan, 5. Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan, 6. Department of Psychiatry, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan, 7. Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan, 8. Agency for Student Support and Disability Resources, Kyoto University, Kyoto, Japan, 9. Department of Psychiatry, Kitasato University School of Medicine, Kanagawa, Japan, 10. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan)

Keywords:antipsychotics, polypharmacy, monotherapy, antipsychotic